NDA 18369, held by Watson Labs. Furosemide.
As of Nov 13, 2026, NDA 18369 (Furosemide), held by Watson Labs, was first approved by FDA on May 14, 1982, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 14, 1982 | Original application | Approved | None posted |
| Furosemide20MG · tablet;oral | Furosemide | Discontinued |
| Furosemide40MG · tablet;oral | Furosemide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
